SunOpta will sell equipment used in the production of flexible, re-sealable pouches from its Allentown, PA facility to Skjodt-Barrett for US$2 million. ###The company plans to discontinue flexible, re-sealable pouch products as part of its ongoing portfolio optimization strategy and Value Creation Plan.###“This asset sale, and discontinuation of the flexible re-sealable pouch business aligns with our stated portfolio optimization strategmagnesium citrate for anxietyy of exiting product lines where the Company is not effectively positioned,” said Dave Colo, CEO of SunOpta. ###“We anticipate the discontinuation of contract manufacturing pouched baby food products to be profit neutral and allow for thqunol magnesium citratee redeployment of capital and resources for investvega zinc citrate 50mgment in more profitable segments of our business where we have enhanced strategic positioning.”###Flexible re-sealable pouch products accounted for US$46 million of revenues in fiscal 2016, and US$10 million of revenues in the first quarter of 2017, and were parsuper magnesium aspartate lactate and citrate para que sirvet of the heapure calcium magnesium citratelthy snacks platform within the consumer products segment. ###SunOpta will continue to produce aseptic beverages from its facility, which were not part of the sale. ###The sale of equipment is expected to close during the fourth quarter of 2017.